Newest first. 5.2k questions across 107 tags.
What I have: FLOW · headache · 15 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I have: Medutest · Janoshik · liraglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The case in front of me: Shanghai · Norway. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Conditions: list of related substances · QYB. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Concretely: Guangzhou · Germany. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
Conditions: a 30G needle · tirzepatide · 10 mg/mL. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that,…
Conditions: PeptideMeter · 98.4%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
The case in front of me: 6.67 mg/mL · tirzepatide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that,…
The specifics, since they change the answer: Wuxi · New Zealand. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
For reference: minus 80 °C · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
The particulars: triglycerides · ecnoglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
Setup, so nobody has to ask: Janoshik · mazdutide. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am…
Stated plainly: QSC · peptide mapping. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
The lot number on the vial matches the certificate, which at least rules out the easy problem. Everything I have found on this is either a forum aside or a product…
Stated plainly: a residual-solvent screen · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
Stated plainly: Nantong · Canada. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do not…
Setup, so nobody has to ask: 30 °C · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
Setup, so nobody has to ask: early satiety · a GLP-1 receptor agonist. The empirical answer seems settled. The explanation does not. If the honest answer is that…
I am reading the trial table rather than the press release, which is why the numbers differ. I can predict the outcome but I cannot explain it, which means I will get…
I have three data points across nine months, which I hope is enough to see a trend. I can parse the result. I am less sure what it licenses me to conclude. I have…
Numbers first: SGN · orforglipron. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists and…
Numbers first: 2 mg · 0.5 mL · sterile water for injection · semaglutide. This is a planning question. I know what my options are; I do not know how to weigh them.…
What I have: eGFR · HbA1c · tirzepatide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
I am asking mechanistically rather than practically — I want the model, not the protocol. This should be a straightforward calculation and I keep getting two…